Skip to main content

Animations

MJFF Publications

1581 - 1590 of 8819 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2023
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29202
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.29205
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2023.112231
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-022-05963-x
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00409-5
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Cognitive dysfunction 1 year after COVID‐19: evidence from eye tracking
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51675
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.723476
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s Disease
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2021.749468
    Citation Count: 19
  • Summary Details
    OPEN
    Title: A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00239-x
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-021-00513-5
    Citation Count: 78
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.